Company Overview and News
Saturday-Monday will see close to two dozen companies announcing their quarterly and full-year results for FY 2018. These are Avenue Supermarts, Balaxi Ventures, DIC India, JP Power and Jayant Agro (on Saturday); Intellect Design Arena (Sunday); and Filatex, Firstsource, Hinduja Ventures, ICICI Bank, INOX Leisure, Pfizer, Rane Holdings, Software Group, Shalby, Tata Chemicals, Tata Coffee, Tata Investment, Trident, Tube Investments, Vijaya Bank and Zee Learn (on Monday).
Around 125 companies including AB Capital, Avanti Feeds, BoB, Bata India, Central Bank, Dredging Corp, Gillette India, GMDC, GE Shipping, HFCL, Hotel Leela Venture, IL&FS Transportation, India Cements, JB Chem, Mahanagar Gas, MCF, Marico, Max Financial, MOIL, Nagarjuna Oil, Oil India, RCF, Rico Auto, SJVN, Sobha, Sona Koyo, Strides Shasun, Sun TV, Suzlon Energy, Tata Investment, Syndicate Bank, UCO Bank and VA Tech will declare their results on Friday.
October last year corporate India saw one of its most bitter corporate battles. It changed things for the House of Tatas and it changed things for the man who is now heading the House of Tatas, N Chandrasekaran.
American inventor Elisha Graves Otis built the first safety elevator in 1952. In the 1870s, Otis entered Europe. Its elevators were installed at the Kremlin, Balmoral Castle, the Hungarian Royal Palace and the Eiffel Tower. In the early 1900s, the Buckingham and the Mysore Palaces were also home to Otis elevators
Tata Global Beverages Ltd (TGBL), a relative laggard in the FMCG sector, is likely to catch the attention of serious investors thanks to its various restructuring initiatives. This stock could benefit from Tata Sons’ initiative of unwinding cross-holdings in group companies, which would help TGBL raise funds. There is also a market buzz (news coverage from CNBC-TV18) that the company plans to sell the non-branded products business.
With N Chandrasekaran taking over as the chairman of the board early this month, Tata Global Beverages Ltd (TGBL) has decided to sell its stake in various Tata group listed company to its parent, Tata Sons, in the next few months. TGBL owns close to Rs 755 crore worth of stake in other Tata group listed companies, especially in Tata Chemicals. According to statistics available with the stock exchanges, TGBL owns a 4.
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- Jubilant Life, Fortis, Marico, Bata, Infosys, Tata Power, Bharat Financial, Satin Creditcare, and Tata Investment.
The JVC will have an equity capital of USD 100 million, and Tata Investment Corporation (TICL) and Koç Holding (KOÇ) will also hold 1% equity stake each, in the new Joint Venture.
A host of firms including Adani Enterprises, Adani SEZ, Amara Raja Batteries, Asahi India, Bharat Forge, Dish TV, Emkay, Fineotex, GE T&D, Gujarat Gas, GVK Power, Jain Irrigation, Jubilant Ind, Kaveri Seed, Lupin, Praj Ind, PNC Infra, Religare Enterprises, Somany Ceramics, Shalimar Paints, Sona Koyo, Sundram Fasteners, Tata Investment, TVS Srichakra and Zee Media will announce their quarterly and annual results for the period ended March 2017 on Wednesday.
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:
Shares of ten Tata group companies rose by 0.13% to 9.39% at 15:12 IST on BSE after Natarajan Chandrasekaran was appointed as the new chairman of Tata Sons from 21 February 2017.
Nusli Wadi, who is at loggerheads with Ratan Tata for ousting him as independent director of group companies, has made a suggestion to wipe out the ₹8,600-crore debt of the company while making serious allegations against the promoters.
Tata Sons, on Tuesday, increased its holding in Tata Motors by about 1.7 per cent through open market purchases.
Speculations have been rife on who will take charge of Tata Sons after the board ousted 48-year old Cyrus Mistry last month. The Economic Times today reports Noel Naval Tata, the media-shy half-brother of Ratan Tata and current Managing Director of Tata International has also emerged as a frontrunner to take over as Tata Sons’ chief.
Smiths Group plc is pleased to announce the appointment of Noel Naval Tata as an independent Non-executive Director with effect from 1 January 2017.
23h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
23h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...